IDEAYA Biosciences Announces Ind Clearance for Ide034, a Potential First-in-Class Bispecific B7h3/Ptk7 Top1 ADC Targeting Multiple Solid Tumor Types

THOMSON REUTERS
Dec 01

IDEAYA Biosciences Announces Ind Clearance for Ide034, a Potential First-in-Class Bispecific B7h3/Ptk7 Top1 ADC Targeting Multiple Solid Tumor Types

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10